Differential control of 17α-hydroxylase and 3β-hydroxysteroid dehydrogenase expression in human adrenocortical H295R cells

Journal of Clinical Endocrinology and Metabolism

Volumn 81, Issue 6, 1996, Pages 2171-2178

  Bird, Ian M ^a,b,c   Pasquarette, Mark M ^a,b   Rainey, William E ^a,b   Mason, J Ian ^a,b,d  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; 3(OR 17)BETA HYDROXYSTEROID DEHYDROGENASE; ALDOSTERONE; ANGIOTENSIN; BUCLADESINE; CHOLESTEROL MONOOXYGENASE (SIDE CHAIN CLEAVING); CYCLIC AMP DEPENDENT PROTEIN KINASE; FORSKOLIN; HYDROCORTISONE; LOSARTAN; LOSARTAN POTASSIUM; PHORBOL 13 ACETATE 12 MYRISTATE; PRASTERONE; PROTEIN KINASE A ACTIVATOR; PROTEIN KINASE C; STEROID 17ALPHA MONOOXYGENASE; UNCLASSIFIED DRUG;

ADRENAL CORTEX CELL; ARTICLE; BINDING AFFINITY; BINDING KINETICS; CONTROLLED STUDY; ENZYME BINDING; ENZYME REGULATION; ENZYME RELEASE; GENE EXPRESSION REGULATION; HORMONE PROTEIN COMPLEX; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DETERMINATION;

3-HYDROXYSTEROID DEHYDROGENASES; ADRENAL CORTEX; ANGIOTENSIN II; BASE SEQUENCE; BUCLADESINE; CHOLESTEROL SIDE-CHAIN CLEAVAGE ENZYME; FORSKOLIN; HUMANS; MOLECULAR SEQUENCE DATA; OLIGONUCLEOTIDE PROBES; PROTEIN KINASE C; STEROID 17-ALPHA-HYDROXYLASE; TETRADECANOYLPHORBOL ACETATE; TUMOR CELLS, CULTURED;

EID: 0029922644     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.81.6.2171     Document Type: Article

References (26)

1. Suzuki T, Sasano H, Sawai T, Mason JI, Nagura H. 1992 Immunohistochemistry and in-situ hybridization of P-45017 alpha (17 alpha-hydroxylase/17, 20-lyase). J Histochem Cytochem. 40:903-908.
2. Conley AJ, Head JR, Stirling DT, Mason JI. 1992 Expression of steroidogenic enzymes in the bovine placenta and fetal adrenal glands throughout gestation. Endocrinology. 130:2641-2650.
3. Simpson ER, Waterman MR. 1988 Regulation of the synthesis of steroidogenic enzymes in adrenal cortical cells by ACTH. Annu Rev Physiol. 50:427-440.
4. Rainey WE, Naville D, Mason JI. 1991 Regulation of 3β-hydroxysteroid dehydrogenase in adrenocortical cells: effects of angiotensin II and transforming growth factor beta. Endocr Res. 17:281-296.
5. Rainey WE, Byrd EW, Sinnokrot RA, Carr BR. 1991 Angiotensin-II activation of cAMP and steroid production in bovine adrenocortical cells: effects of nonpeptide angiotensin-II antagonists. Mol Cell Endocrinol. 81:33-41.
6. Bird IM, Magness RR, Mason JI, Rainey WE. 1992 Angiotensin-II acts via the type 1 receptor to inhibit 17α-hydroxylase cytochrome P450 expression in ovine adrenocortical cells. Endocrinology. 130:3113-3121.
7. Naville D, Lebrethon MC, Kermabon AY, Rouer E, Benarous R, Saez JM. 1993 Characterization and regulation of angiotensin II type-1 receptor (binding and mRNA) in human adrenal fasciculata reticularis cells. FEBS Lett. 312: 776-782.
8. 1-R mRNA levels in human adrenocortical cells. Endocr Res. 21:169-182.
9. Bird IM, Mason JI, Oka K, Rainey WE. 1993 Angiotensin-II stimulates an increase in cAMP and expression of 17α-hydroxylase cytochrome P450 in fetal bovine adrenocortical cells. Endocrinology. 132:932-934.
10. Rainey WE, Oka K, Magness RR, Mason JI. 1991 Ovine fetal adrenal synthesis of cortisol: regulation by ACTH, angiotensin II and transforming growth factor beta. Endocrinology. 129:1784-1790.
11. Mason JI, Bird IM, Rainey WE. 1992 Regulation of adrenal 3β-hydroxysteroid dehydrogenase/Δ5->4-isomerase and P45017α-hydroxylase expression. Cellular and Molecular Biology of the Adrenal Cortex. In: Saez JM, Brownie AC, Capponi A, Chambaz EM, Mantero F, eds. Colloque INSERM/John Libbey Eurotext Ltd.; vol 222:111-122.
12. McAllister JA, Hornsby PJ. 1988 Dual regulation of 3β-hydroxysteroid dehydrogenase, 17α-hydroxylase, and dehydroepiandrosterone sulfotransferase by adenosine 3′,5′-monophosphate and activators of protein kinase C in cultured human adrenocortical cells. Endocrinology. 122:2012-2018.
13. Cheung CY, Flasch MV, Hornsby PJ. 1992 Expression of 17α-hydroxylase and 3β-hydroxysteroid dehydrogenase in fetal human adrenocortical cells transfected with SV40 T antigen. J Mol Endocrinol. 9:7-17.
14. Lebrethon MC, Jaillard C, Defayes G, Begeot M, Saez JM. 1944 Human cultured adrenal fasciculata-reticularis cells are targets for angiotensin-II: effects on cytochrome 450 side-chain cleavage, cytochrome P450 17α-hydroxylase, and 3β-hydroxysteroid dehydrogenase messenger ribonucleic acid and proteins and on steroidogenic responsiveness tocorticotropin and angiotensin-II. J Clin Endocrinol Metab. 78:1212-1219.
15. Di Blassio AM, Voutilainen R, Jaffe RB, Miller WL. 1987 Hormonal regulation of messenger ribonucleic acids for P450scc (cholesterol side-chain cleavage enzyme) and P450c17 (17 α-hydroxylase/17, 20-lyase) in cultured human fetal adrenal cells. J Clin Endocrinol Metab. 65:170-175.
16. Rainey WE, Bird IM, Mason JI. 1994 The NCl-H295 cell line: a pluripotent model for human adrenocortical studies. Mol Cell Endocrinol. 100:45-50.
17. Rainey WE, Bird IM, Sawetawan C, et al. 1993 Regulation of human adrenal carcinoma cell (NCl-H295) production of C19 steroids. J Clin Endocrinol Metab. 77:731-737.
18. Milewich L, Shaw CE, Mason JI, Carr BR, Blomquist CH, Thomas JL. 1993 3 beta-hydroxysteroid dehydrogenase activity in tissues of the human fetus determined with 5 alpha-androstane-3 beta, 17 beta-diol, and dehydroepiandrosterone as substrates. J Steroid Biochem Mol Biol. 45:525-537.
19. Bradshaw KD, Waterman MR, Couch RT, Simpson ER, Zuber MX. 1987 Characterization of complementary deoxyribonucleic acid for human adrenocortical 17α-hydroxylase: a probe for analysis of 17α-hydroxylase deficiency. Mol Endocrinol. 1:348-354.
20. Bird IM, Hanley NA, Word RA, et al. 1993 Human NCl-H295 adrenocortical carcinoma cells: a model for angiotensin-II-responsive aldosterone secretion. Endocrinology. 133:1555-1561.
21. Bird IM, Mason JI, Rainey WE. 1994 Regulation of type 1 angiotensin II receptor messenger ribonucleic acid expression in human adrenocortical carcinoma H295 cells. Endocrinology. 134:2468-2474.
22. 2+-regulated expression of steroid hydroxylnses in H295R human adrenocortical cells. Endocrinology. 136: 5677-5684.
23. Staels B, Hum DW, Miller WL. 1943 Regulation of steroidogenesis in NCl-H245 cells: A cellular model of the human fetal adrenal. Mol Endocrinol. 7:423-433.
24. Mason JI, Bird IM, Rainey WE. 1996 Adrenal androgen biosynthesis with special attention to P450c17. Ann NY Acad Sci. 774:47-58.
25. Holland OB, Mathis JI, Bird IM, Rainey WE. 1443 Angiotensin increases aldosterone synthase mRNA levels in human NCl-H245 cells. Mol Cell Endocrinol. 94:R9-R13.
26. Rainey WE, Bird IM, Mason JI. 1992 Angiotensin-II-directed glomerulosa cell function in fetal adrenal cells. J Steroid Biochem Mol Biol. 43:847-854.